Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 8
1981 8
1982 9
1983 42
1984 63
1985 93
1986 81
1987 166
1988 156
1989 250
1990 235
1991 209
1992 199
1993 208
1994 165
1995 150
1996 152
1997 122
1998 114
1999 124
2000 131
2001 107
2002 101
2003 90
2004 81
2005 82
2006 82
2007 71
2008 90
2009 76
2010 66
2011 76
2012 69
2013 62
2014 63
2015 68
2016 57
2017 64
2018 53
2019 53
2020 58
2021 56
2022 62
2023 63
2024 70
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,236 results

Results by year

Filters applied: . Clear all
Page 1
Systematic Review of Intrathecal Nicardipine for the Treatment of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage.
Hafeez S, Grandhi R. Hafeez S, et al. Neurocrit Care. 2019 Oct;31(2):399-405. doi: 10.1007/s12028-018-0659-9. Neurocrit Care. 2019. PMID: 30607826
Intrathecal nicardipine injections for aSAH-related cerebral vasospasm appears efficacious and safe. Administration of 4 mg of nicardipine every 12 hours was the most commonly reported dosing regimen. Intrathecal nicardipine decreases mean flow velocities on …
Intrathecal nicardipine injections for aSAH-related cerebral vasospasm appears efficacious and safe. Administration of 4 mg of nic …
Comparison of Clevidipine and Nicardipine for Acute Blood Pressure Reduction in Hemorrhagic Stroke.
Saldana S, Breslin J 2nd, Hanify J, Heierman T, Larizadeh K, Sanchez M, Phipps W. Saldana S, et al. Neurocrit Care. 2022 Jun;36(3):983-992. doi: 10.1007/s12028-021-01407-w. Epub 2021 Dec 13. Neurocrit Care. 2022. PMID: 34904214
Lowering systolic blood pressure (SBP) with an intravenous antihypertensive, such as nicardipine or clevidipine, may reduce the risk of hematoma expansion and rebleeding. Previous studies comparing nicardipine and clevidipine in patients with stroke found no signifi …
Lowering systolic blood pressure (SBP) with an intravenous antihypertensive, such as nicardipine or clevidipine, may reduce the risk …
Nicardipine versus Labetalol for Hypertension during Acute Stroke: A Systematic Review and Meta-Analysis.
Hao F, Yin S, Tang L, Zhang X, Zhang S. Hao F, et al. Neurol India. 2022 Sep-Oct;70(5):1793-1799. doi: 10.4103/0028-3886.359214. Neurol India. 2022. PMID: 36352567 Free article. Review.
BACKGROUND AND OBJECTIVE: Current recommendations prescribe either nicardipine or labetalol as the first-line treatment for acute hypertension due to ease of use, availability, and low price. ...The incidence of adverse events was significantly higher in the nicardipine …
BACKGROUND AND OBJECTIVE: Current recommendations prescribe either nicardipine or labetalol as the first-line treatment for acute hyp …
Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications.
Curran MP, Robinson DM, Keating GM. Curran MP, et al. Drugs. 2006;66(13):1755-82. doi: 10.2165/00003495-200666130-00010. Drugs. 2006. PMID: 16978041 Review.
Nicardipine is a water soluble calcium channel antagonist, with predominantly vasodilatory actions. ...IV nicardipine was as effective as IV nitroprusside in the short-term reduction of BP in patients with severe or postoperative hypertension. ...
Nicardipine is a water soluble calcium channel antagonist, with predominantly vasodilatory actions. ...IV nicardipine was as e …
Therapeutic and safety outcomes of intracoronary nicardipine in coronary artery disease patients: a systematic review.
Rehan ST, Imran L, Salim A, Javed SO, Sohail A, Hussain HU, Ahmed J, Yasmin F, Islam MS, Asghar MS. Rehan ST, et al. Future Cardiol. 2023 Mar;19(3):163-174. doi: 10.2217/fca-2022-0085. Epub 2023 Jun 2. Future Cardiol. 2023. PMID: 37264944 Review.
Aim: This systematic review aimed to shed light on the efficacy of intracoronary (IC) nicardipine in treating no reflow with CAD undergoing revascularization. Methods: Literature search was performed on databases with following eligibility criteria: adult patients with CAD …
Aim: This systematic review aimed to shed light on the efficacy of intracoronary (IC) nicardipine in treating no reflow with CAD unde …
Clinical pharmacokinetics and pharmacodynamics of nicardipine; a systematic review.
Ayub A, Zamir A, Imran I, Saeed H, Majeed A, Aziz M, Alqahtani F, Rasool MF. Ayub A, et al. Expert Opin Drug Metab Toxicol. 2024 Nov-Dec;20(11-12):1053-1067. doi: 10.1080/17425255.2024.2402481. Epub 2024 Sep 16. Expert Opin Drug Metab Toxicol. 2024. PMID: 39252195 Review.
INTRODUCTION: Nicardipine is a type of calcium channel blocker that is commonly used in the treatment of angina pectoris, hypertension, and related cardiovascular disorders. ...The area under the plasma concentration vs. time curve from zero to infinity (AUC(0-)) and maxim …
INTRODUCTION: Nicardipine is a type of calcium channel blocker that is commonly used in the treatment of angina pectoris, hypertensio …
Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models.
Li X, Chen Y, Bai L, Zhao R, Wu Y, Xie ZR, Wu JM, Bowen NJ, Danaher A, Cook N, Li D, Qui M, Du Y, Fu H, Osunkoya AO, Kucuk O, Wu D. Li X, et al. Br J Cancer. 2023 Sep;129(5):884-894. doi: 10.1038/s41416-023-02359-y. Epub 2023 Jul 20. Br J Cancer. 2023. PMID: 37474721 Free PMC article.
As a monotherapy, nicardipine effectively inhibited the skeletal growth of chemoresistant C4-2B-TaxR tumours. As a combination regimen, nicardipine synergistically enhanced the in vivo efficacy of docetaxel against C4-2 xenografts. ...
As a monotherapy, nicardipine effectively inhibited the skeletal growth of chemoresistant C4-2B-TaxR tumours. As a combination regime …
Cardiovascular effects of nicardipine.
Pepine CJ, Lambert CR. Pepine CJ, et al. Angiology. 1990 Nov;41(11 Pt 2):978-86. Angiology. 1990. PMID: 2248426 Review.
Nicardipine, a new 1-4 dihydropyridine calcium antagonist, has chemical properties that allow oral and stable intravenous preparations. ...Alone and in combination with other antihypertensive agents, nicardipine has been shown to be effective in the treatment of mil …
Nicardipine, a new 1-4 dihydropyridine calcium antagonist, has chemical properties that allow oral and stable intravenous preparation …
4,236 results